These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2068454)

  • 1. [Effect of allopurinol on the indicators of immunity in podagra and experimental hyperuricemia].
    Siniachenko OV; Nikolenko IuI; Diadyk AI; Bortnik VA; Okushko RV
    Revmatologiia (Mosk); 1991; (1):12-5. PubMed ID: 2068454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-deoxyribonucleic acid antibodies in podagra].
    Nikolenko IuI; Siniachenko OV; Diadyk AI
    Revmatologiia (Mosk); 1989; (2):30-5. PubMed ID: 2678395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of hyperuricemia with allopurinol].
    Hood B; Olander R; Sjöberg KH; Orndahl G
    Lakartidningen; 1968 Feb; 65(6):574-82. PubMed ID: 5723559
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allopurinol treatment of hyperuricemia].
    Nissen NI; Paikin H
    Nord Med; 1967 Oct; 78(41):1320-4. PubMed ID: 6054472
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
    [No Abstract]   [Full Text] [Related]  

  • 11. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of allopurinol in long-term treatments for optimal effect].
    Fenner H
    Fortschr Med; 1980 Mar; 98(10):(373-6). PubMed ID: 7372221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of the allopurinol treatment of patients with gouty nephropathy].
    Siniachenko OV; Diadyk AI; Nikolenko IuI; Antonov AA; Gusak IIa; Zhitomirskiĭ MI
    Vrach Delo; 1991 Jul; (7):98-101. PubMed ID: 1771852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent control of hyperuricemia in the treatment of gout.
    Bull PW; Scott JT
    J Rheumatol; 1989 Sep; 16(9):1246-8. PubMed ID: 2681764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
    Serre H; Simon L; Claustre J
    Sem Hop; 1970 Dec; 46(50):3295-301. PubMed ID: 4323560
    [No Abstract]   [Full Text] [Related]  

  • 17. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibition of uric acid synthesis with Allopurinol].
    Holländer E
    Orv Hetil; 1968 Oct; 109(41):2272-4. PubMed ID: 5715143
    [No Abstract]   [Full Text] [Related]  

  • 20. [De novo purine biosynthesis. In vitro measurement in hyperuricemia (author's transl)].
    Chanard J; Kamoun P; Pleau JM; Brami M; Brunois JP; Funck-Brentano JL
    Nouv Presse Med; 1977 Sep; 6(29):2579-82. PubMed ID: 909738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.